Resolution of vanishing bile duct syndrome in a patient associated with refractory hodgkin lymphoma following Anti-PD-1 therapy: a case report and literature review. [PDF]
Ann HematolLin YC +6 more
europepmc +1 more source
A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives. [PDF]
PLoS OneZhang C +6 more
europepmc +1 more source
Neoadjuvant chemotherapy in locally advanced clear cell carcinoma of the cervix leading to complete disease resolution; a case report. [PDF]
Gynecol Oncol RepFronk E, Whittum M, Poljak D, Smith A.
europepmc +1 more source
TCRcloud: a global visualization tool for T-cell and B-cell receptor transcripts. [PDF]
J Transl Medde Sousa E +10 more
europepmc +1 more source
Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. [PDF]
Ther Adv Med OncolGrau Béjar JF +6 more
europepmc +1 more source
Genetic and Clinical Characteristics of Patients With Tumor Mutation Burden-High Unresectable Pancreatic Cancer and the Efficacy of Pembrolizumab Treatment. [PDF]
Cancer Rep (Hoboken)Kai Y +14 more
europepmc +1 more source
Steroid-Refractory Pembrolizumab-Induced Haemophagocytic Lymphohistiocytosis (HLH) Successfully Treated With Anakinra: A Case Report. [PDF]
CureusKaudlay Sathyanarayana PK +4 more
europepmc +1 more source
Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework. [PDF]
Bull Math BiolHawi G, Kim PS, Lee PP.
europepmc +1 more source